CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,173 | -76.7% | 3,351 | -73.2% | 0.00% | -83.3% |
| Q2 2023 | $168,268 | +50736.3% | 12,520 | -37.2% | 0.01% | -45.5% |
| Q1 2023 | $331 | +298.8% | 19,944 | +343.0% | 0.01% | +266.7% |
| Q4 2022 | $83 | -100.0% | 4,502 | -82.1% | 0.00% | -40.0% |
| Q3 2022 | $322,000 | +312.8% | 25,107 | +125.5% | 0.01% | +150.0% |
| Q2 2022 | $78,000 | -78.0% | 11,132 | -73.9% | 0.00% | -33.3% |
| Q1 2022 | $354,000 | +321.4% | 42,629 | +242.0% | 0.00% | +200.0% |
| Q4 2021 | $84,000 | -24.3% | 12,465 | -40.7% | 0.00% | -66.7% |
| Q3 2021 | $111,000 | +146.7% | 21,024 | +168.3% | 0.00% | +200.0% |
| Q2 2021 | $45,000 | -32.8% | 7,837 | -45.7% | 0.00% | 0.0% |
| Q1 2021 | $67,000 | +123.3% | 14,446 | +60.9% | 0.00% | 0.0% |
| Q4 2020 | $30,000 | -93.9% | 8,979 | -94.5% | 0.00% | -80.0% |
| Q3 2020 | $489,000 | +404.1% | 164,561 | +690.5% | 0.01% | +25.0% |
| Q2 2020 | $97,000 | +73.2% | 20,818 | +38.8% | 0.00% | -20.0% |
| Q4 2019 | $56,000 | +107.4% | 15,000 | +196.4% | 0.01% | +150.0% |
| Q3 2019 | $27,000 | +28.6% | 5,061 | -53.0% | 0.00% | 0.0% |
| Q4 2018 | $21,000 | +950.0% | 10,769 | +2320.0% | 0.00% | – |
| Q3 2018 | $2,000 | -75.0% | 445 | -86.1% | 0.00% | -100.0% |
| Q1 2018 | $8,000 | -83.7% | 3,198 | -74.8% | 0.00% | -83.3% |
| Q4 2017 | $49,000 | +28.9% | 12,677 | -16.9% | 0.01% | +100.0% |
| Q3 2017 | $38,000 | +1800.0% | 15,261 | +1424.6% | 0.00% | – |
| Q1 2017 | $2,000 | -77.8% | 1,001 | -87.6% | 0.00% | -100.0% |
| Q4 2016 | $9,000 | +12.5% | 8,097 | +5.0% | 0.00% | 0.0% |
| Q3 2016 | $8,000 | -80.0% | 7,710 | -86.2% | 0.00% | -75.0% |
| Q2 2016 | $40,000 | +700.0% | 55,783 | +1142.7% | 0.00% | +300.0% |
| Q1 2016 | $5,000 | +25.0% | 4,489 | +158.0% | 0.00% | 0.0% |
| Q4 2015 | $4,000 | -83.3% | 1,740 | -78.0% | 0.00% | -50.0% |
| Q3 2015 | $24,000 | – | 7,901 | +7801.0% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 100 | -97.7% | 0.00% | -100.0% |
| Q1 2015 | $19,000 | +1800.0% | 4,301 | +705.4% | 0.00% | – |
| Q1 2014 | $1,000 | -96.9% | 534 | -96.8% | 0.00% | -100.0% |
| Q4 2013 | $32,000 | – | 16,540 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |